Lilly’s $400 Billion Surge Reshapes Big Pharma, Rally
Eli Lilly has added roughly $400 billion in market value over the past year, fueling a dramatic shift in Big Pharma a...
Millennials can benefit from strategic wealth management. Discover tips to effectively grow and manage your financial assets.
18,493 articlesEli Lilly has added roughly $400 billion in market value over the past year, fueling a dramatic shift in Big Pharma a...
Could XRP slip below $2 by 2027? This guide breaks down the three big hurdles, explains why a lower price is plausibl...
Two separate California cases show how funds meant for students can be diverted into luxury purchases. This article e...
Galaxy Digital warns the CLARITY Act may stall in 2026 without a timely committee vote, with lawmakers juggling other...
Two popular healthcare ETFs—IHE and IBB—offer very different routes to exposure: established pharma vs biotech innova...
Netflix has transformed how we watch TV, but investors are asking if the stock can reach $200. This article breaks do...
A high-net-worth retiree confronts a sizable required minimum distribution that could push income into the upper tax ...
Fresh insider purchases in three battered names point to growing belief that cash flow and demand visibility can rebo...
Veteran market commentator Jim Cramer signaled a shift to caution, saying funds are drying up for big tech deals. The...
More than 3,800 workers at a large Colorado meatpacking plant walked off Monday, marking the first major U.S. beef sl...
XRP sits in a tight range around $1.10 as traders await regulatory developments. A clean break above $1.20 could redr...
PayPal’s collapsing stock price is harming YieldMax’s PYPY ETF, where income from options premiums no longer keeps pa...